HomeNewsTrendsFeaturesFacing existential threat: COVID-19 lockdown takes heavy toll on bars, microbreweries

Facing existential threat: COVID-19 lockdown takes heavy toll on bars, microbreweries

Bereft of approvals to home-delivery cocktails-on-the-go and facing the difficulties of socially distancing within crowded spaces, bars are facing an existential threat. Industry bodies and alcoholic beverage companies have come to the rescue of a segment that may take at least two years to revive.

July 20, 2020 / 17:40 IST
Story continues below Advertisement

If you thought that the restaurant industry has been hit hard by the global pandemic, here is far more troubling news: bars are having it tougher.

Restaurants can mitigate losses with home deliveries, curated experiences, online master classes and bakeries. There is also the possibility to open up with social distancing norms. But how do you open up a space that is made for people jostling, packed like Mumbai’s pre-COVID day’s peak-hour rush in a local train compartment? Unless you are referring to a fancy bar in an equally fancier hotel, even the most upmarket bars do not allow for social distancing.

Story continues below Advertisement

Globally, there are instances of how bars were forced to shut down within days of opening up and are being viewed as crucibles for infection spread. A July 3, 2020 report of trade association Hospitality (UKH), which tracks bars and restaurants in London, states, “No hotel buffets, no cutlery laid out on tables, and no drinks at the bar!”

Robot bartender.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show